Radiomics models for diagnosing microvascular invasion in hepatocellular carcinoma: which model is the best model?


Journal

Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931

Informations de publication

Date de publication:
28 Aug 2019
Historique:
received: 18 06 2019
accepted: 14 08 2019
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 23 11 2019
Statut: epublish

Résumé

To explore the feasibility of diagnosing microvascular invasion (MVI) with radiomics, to compare the diagnostic performance of different models established by each method, and to determine the best diagnostic model based on radiomics. A retrospective analysis was conducted with 206 cases of hepatocellular carcinoma (HCC) confirmed through surgery and pathology in our hospital from June 2015 to September 2018. Among the samples, 88 were MVI-positive, and 118 were MVI-negative. The radiomics analysis process included tumor segmentation, feature extraction, data preprocessing, dimensionality reduction, modeling and model evaluation. A total of 1044 sets of texture feature parameters were extracted, and 21 methods were used for the radiomics analysis. All research methods could be used to diagnose MVI. Of all the methods, the LASSO+GBDT method had the highest accuracy, the LASSO+RF method had the highest sensitivity, the LASSO+BPNet method had the highest specificity, and the LASSO+GBDT method had the highest AUC. Through Z-tests of the AUCs, LASSO+GBDT, LASSO+K-NN, LASSO+RF, PCA + DT, and PCA + RF had Z-values greater than 1.96 (p<0.05). The DCA results showed that the LASSO + GBDT method was better than the other methods when the threshold probability was greater than 0.22. Radiomics can be used for the preoperative, noninvasive diagnosis of MVI, but different dimensionality reduction and modeling methods will affect the diagnostic performance of the final model. The model established with the LASSO+GBDT method had the optimal diagnostic performance and the greatest diagnostic value for MVI.

Identifiants

pubmed: 31455432
doi: 10.1186/s40644-019-0249-x
pii: 10.1186/s40644-019-0249-x
pmc: PMC6712704
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60

Subventions

Organisme : Natural Science Foundation of Shandong Province (CN)
ID : ZR2017BH04 4

Références

Hepatology. 2005 Nov;42(5):1208-36
pubmed: 16250051
J Gastroenterol. 2006 Oct;41(10):987-95
pubmed: 17096068
Surgery. 2007 Mar;141(3):330-9
pubmed: 17349844
Ann Surg Oncol. 2008 May;15(5):1375-82
pubmed: 18324443
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Liver Cancer. 2015 Mar;4(1):39-50
pubmed: 26020028
Cold Spring Harb Perspect Med. 2015 Jul 17;5(9):a021535
pubmed: 26187874
Radiology. 2016 May;279(2):432-42
pubmed: 26653683
Diagn Interv Radiol. 2016 Mar-Apr;22(2):125-32
pubmed: 26782155
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Radiology. 2016 Dec;281(3):947-957
pubmed: 27347764
Medicine (Baltimore). 2016 Jun;95(26):e4034
pubmed: 27368028
Jpn J Clin Oncol. 2016 Dec;46(12):1075-1080
pubmed: 27677661
Clin Cancer Res. 2017 Aug 1;23(15):4259-4269
pubmed: 28280088
Chin Clin Oncol. 2017 Apr;6(2):21
pubmed: 28482674
J Med Imaging (Bellingham). 2017 Oct;4(4):041303
pubmed: 28840174
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762
pubmed: 28975929
J Zhejiang Univ Sci B. 2018 Jan.;19(1):6-24
pubmed: 29308604
Diagn Interv Radiol. 2018 May-Jun;24(3):121-127
pubmed: 29770763
PLoS One. 2018 May 17;13(5):e0197488
pubmed: 29771954
Clin Mol Hepatol. 2019 Mar;25(1):21-29
pubmed: 30441889
Diagnostics (Basel). 2018 Dec 27;9(1):null
pubmed: 30591628
Eur Radiol. 2019 Jul;29(7):3595-3605
pubmed: 30770969
J Hepatol. 2019 Jun;70(6):1133-1144
pubmed: 30876945
Pharmacol Res Perspect. 2019 Jun 20;7(4):e00486
pubmed: 31249691

Auteurs

Ming Ni (M)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Xiaoming Zhou (X)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China. zhouxm@qduhospital.cn.

Qian Lv (Q)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Zhiming Li (Z)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Yuanxiang Gao (Y)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Yongqi Tan (Y)

College of Computer Science and Engineering, Shandong University of Science and Technology, Qingdao, Shandong, China.

Jihua Liu (J)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Fang Liu (F)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Haiyang Yu (H)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Linlin Jiao (L)

Intervention Medical Center, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China.

Gang Wang (G)

Department of Radiology, The Affiliated Hospital of QingDao University, QingDao, ShanDong, China. 313682216@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH